Trial · NCT00644657
The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization
NCT00644657, Not applicable, Completed, University of Oklahoma; results first posted 2011-10-07
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization. Trials, record NCT00644657. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00644657
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization
- NCT number
- NCT00644657
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 27 participants, actual
- Lead sponsor
- University of Oklahoma
- Conditions
- Coronary Artery Disease, Chest Pain
- Interventions
- Clopidogrel
- First posted
- 2008-03-27
- Last updated
- 2011-10-07
- Results first posted
- 2011-10-07
- Limitations and caveats
- Limited to primarily Male VA population.
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The Percentage of Coated Platelets After the Administration of Clopidogrel in Patients Undergoing Cardiac Catheterization and/or Angioplasty | 24 hours after the administration of clopidotrel | The percentage of platelets that are collagen coated after the administration of clopidogrel. |
| Secondary | The Percentage of Coated Platelets After Coronary Angiography and/or PCI | 6 hrs after procedure | The percentage of coated platelets 24 hours after coronary angiography and/or PCI |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | The Percentage of Coated Platelets After the Administration of Clopidogrel in Patients Undergoing Cardiac Catheterization and/or Angioplasty | 24 hours after the administration of clopidotrel | Percent of platelets that are coated. | MEAN | |
| SECONDARY | The Percentage of Coated Platelets After Coronary Angiography and/or PCI | 6 hrs after procedure | Percentage of platelets that are coated | MEAN |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The Percentage of Coated Platelets After the Administration of Clopidogrel in Patients Undergoing Cardiac Catheterization and/or Angioplasty | Clopidogrel Loading Dose | 32.8 | Standard Deviation 13.6 | Percent of platelets that are coated. | |
| The Percentage of Coated Platelets After Coronary Angiography and/or PCI | Clopidogrel Loading Dose | 33.9 | Standard Deviation 12.3 | Percentage of platelets that are coated |
Source ClinicalTrials.gov
Participant flow3
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Clopidogrel Loading Dose | 27 | |
| Overall Study | COMPLETED | Clopidogrel Loading Dose | 27 | |
| Overall Study | NOT COMPLETED | Clopidogrel Loading Dose | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Clopidogrel Loading Dose | ||
| Total, other adverse events | Clopidogrel Loading Dose | 0 | 27 |
| Total, serious adverse events | Clopidogrel Loading Dose | 0 | 27 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00644657
GET https://conductscience.org/api/trials/v1/NCT00644657/registered